Skip to content
NewsBlazeAU – Lifestyle
Author:
Keros Therapeutics, Inc.
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
June 1, 2026
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
May 14, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
March 26, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
March 26, 2026